Publication | Open Access
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
59
Citations
90
References
2023
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1